Daraxonrasib combined with chemotherapy stops tumor growth in 90% of pancreatic cancer patients
A trial of 61 participants with advanced pancreatic cancer found that daraxonrasib combined with chemotherapy stopped tumor growth in 90% of patients. Dr. Wungki…
